Quidel | QDEL - Debt


Quidel reported $2.87B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Agilent USD 3.36B 1000K Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Bruker USD 1.82B 153.5M Jun/2026
Cerus USD 84.16M 791K Dec/2024
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Danaher USD 26.56B 8.07B Jun/2026
Haemonetics USD 1.22B 153K Mar/2026
Illumina USD 2.54B 9M Mar/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
Merit Medical Systems USD 821.56M 9K Mar/2026
Mettler Toledo International USD 2.23B 76.47M Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
Neogen USD 793.7M 400K Mar/2026
OraSure Technologies USD 782K 465K Jun/2024
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quidel USD 2.87B 40.8M Mar/2026
Revvity USD 3.35B 48.03M Mar/2026
STAAR Surgical USD 37.29M 1.06M Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Waters USD 5.57B 4.08B Mar/2026